FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000893138> ?p ?o ?g. }

• W2000893138 endingPage "40" @default.
• W2000893138 startingPage "33" @default.
• W2000893138 abstract "The purpose of this review is to address the issue of endpoints in paediatric oncology. Oncologists use this term to refer to an outcome they are trying to measure with a clinical trial, which may become accordingly the object of scientific articles. The outcome measured may concern both efficacy and safety, although from different perspectives.Based on both literature and experience developed in clinical trials, the different types of endpoints have been critically analysed in their power to provide the highest information of therapeutic interest (efficacy and safety) with the least risk and discomfort for the individual. Primary, secondary and surrogate endpoints have been distinguished. The most relevant differences have been discussed in comparison with adult oncology settings of endpoints.The rarity of cancer in childhood and adolescence and the objective difficulty of enrolling statistically conceivable numbers of individuals have determined the utmost positive development of large scale, multinational clinical trials. The most interesting consequence is that the impact of multiplicity interferences, which is usually present in virtually all clinical trials developed for adults with cancer, is not a common event in paediatric oncology. Nevertheless, many of the questions concerning the different impact on outcome and survival of clinical trials developed in adult oncology remain unanswered due to the objective limitations still existing in terms of cure compared with paediatric oncology. The powerful consistency of cure rate, as the most relevant endpoint of clinical trials developed in paediatric oncology, addresses additional considerations to support the relevant differences existing between adult and paediatric oncology: both the development of clinical trials with different aims (confirmatory versus primary response) and the limited impact of multiplicity limitations may determine different implications regarding the meaning of endpoints in paediatric and adult oncology.The aim of cancer treatment is to improve survival (SUR) and quality of life (QoL), but some restraints on the conduct of clinical trials may make these goals unattainable. Clinical trial endpoints represent a measure method aimed to grant answers to questions addressed by the clinical trial itself. The effect of the new regulation is expected to stimulate high-quality research and provide robust information on paediatric drugs to increase the availability of such drugs to children." @default.
• W2000893138 created "2016-06-24" @default.
• W2000893138 creator A5017500760 @default.
• W2000893138 creator A5024157790 @default.
• W2000893138 creator A5043451240 @default.
• W2000893138 creator A5061181757 @default.
• W2000893138 creator A5073523995 @default.
• W2000893138 date "2010-11-18" @default.
• W2000893138 modified "2023-10-12" @default.
• W2000893138 title "Endpoints in paediatric oncology" @default.
• W2000893138 cites W2015758016 @default.
• W2000893138 cites W2071913549 @default.
• W2000893138 cites W2096913417 @default.
• W2000893138 cites W2127184545 @default.
• W2000893138 cites W2149026567 @default.
• W2000893138 cites W2155949904 @default.
• W2000893138 cites W4248942669 @default.
• W2000893138 doi "https://doi.org/10.1007/s00228-010-0923-1" @default.
• W2000893138 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21085937" @default.
• W2000893138 hasPublicationYear "2010" @default.
• W2000893138 type Work @default.
• W2000893138 sameAs 2000893138 @default.
• W2000893138 citedByCount "2" @default.
• W2000893138 countsByYear W20008931382013 @default.
• W2000893138 countsByYear W20008931382023 @default.
• W2000893138 crossrefType "journal-article" @default.
• W2000893138 hasAuthorship W2000893138A5017500760 @default.
• W2000893138 hasAuthorship W2000893138A5024157790 @default.
• W2000893138 hasAuthorship W2000893138A5043451240 @default.
• W2000893138 hasAuthorship W2000893138A5061181757 @default.
• W2000893138 hasAuthorship W2000893138A5073523995 @default.
• W2000893138 hasBestOaLocation W20008931382 @default.
• W2000893138 hasConcept C121608353 @default.
• W2000893138 hasConcept C126322002 @default.
• W2000893138 hasConcept C141341695 @default.
• W2000893138 hasConcept C143998085 @default.
• W2000893138 hasConcept C177713679 @default.
• W2000893138 hasConcept C203092338 @default.
• W2000893138 hasConcept C2776598537 @default.
• W2000893138 hasConcept C2909914741 @default.
• W2000893138 hasConcept C535046627 @default.
• W2000893138 hasConcept C71924100 @default.
• W2000893138 hasConceptScore W2000893138C121608353 @default.
• W2000893138 hasConceptScore W2000893138C126322002 @default.
• W2000893138 hasConceptScore W2000893138C141341695 @default.
• W2000893138 hasConceptScore W2000893138C143998085 @default.
• W2000893138 hasConceptScore W2000893138C177713679 @default.
• W2000893138 hasConceptScore W2000893138C203092338 @default.
• W2000893138 hasConceptScore W2000893138C2776598537 @default.
• W2000893138 hasConceptScore W2000893138C2909914741 @default.
• W2000893138 hasConceptScore W2000893138C535046627 @default.
• W2000893138 hasConceptScore W2000893138C71924100 @default.
• W2000893138 hasIssue "S1" @default.
• W2000893138 hasLocation W20008931381 @default.
• W2000893138 hasLocation W20008931382 @default.
• W2000893138 hasLocation W20008931383 @default.
• W2000893138 hasLocation W20008931384 @default.
• W2000893138 hasLocation W20008931385 @default.
• W2000893138 hasLocation W20008931386 @default.
• W2000893138 hasOpenAccess W2000893138 @default.
• W2000893138 hasPrimaryLocation W20008931381 @default.
• W2000893138 hasRelatedWork W1510385229 @default.
• W2000893138 hasRelatedWork W1549397452 @default.
• W2000893138 hasRelatedWork W1919236762 @default.
• W2000893138 hasRelatedWork W2089903975 @default.
• W2000893138 hasRelatedWork W2109605661 @default.
• W2000893138 hasRelatedWork W2142836028 @default.
• W2000893138 hasRelatedWork W2167313910 @default.
• W2000893138 hasRelatedWork W2169374891 @default.
• W2000893138 hasRelatedWork W4288061592 @default.
• W2000893138 hasRelatedWork W4299891181 @default.
• W2000893138 hasVolume "67" @default.
• W2000893138 isParatext "false" @default.
• W2000893138 isRetracted "false" @default.
• W2000893138 magId "2000893138" @default.
• W2000893138 workType "article" @default.